News

Ampersand Biomedicines Appoints Elizabeth Mily to Board of Directors

BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Ampersand Biomedicines, a multi-product platform company developing smarter medicines that act specifically at…

10 months ago

Chicago Biomedical Consortium to Serve as Regional Host Committee Chair for BioCentury’s Grand Rounds – U.S. Conference

Chicago to host 2025 Grand Rounds ConferenceCHICAGO, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The Chicago Biomedical Consortium (“CBC”), a Midwest center…

10 months ago

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences

PRINCETON, N.J., Feb. 11, 2025 (GLOBE NEWSWIRE) -- PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision oncology company pioneering the discovery…

10 months ago

IN8bio Reports Updated Positive Results from Phase 1 Trial of INB-100 in Leukemia Patients

100% of acute myeloid leukemia (AML) patients across both original and expansion cohorts remain in complete remission (CR), with a…

10 months ago

Milestone Pharmaceuticals to Host Commercial Launch Plan Investor Event in New York on February 25, 2025

MONTREAL and CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on…

10 months ago

EvolveImmune Appoints Kristen M. Hege, M.D. to Its Board of Directors

Dr. Hege joins the Board as EvolveImmune prepares to enter the clinic in mid-2025 with EVOLVE104, its lead trispecific T…

10 months ago

Blue Point Brewing Announces 5th Annual Shakedown on Main Street Festival

Blue Point Hosts Epic Summer Kickoff with Performances by Ripe, Badfish, Dogs in a Pile, and Ernie & the Band!PATCHOGUE,…

10 months ago

Aclarion Receives US Patent to Protect Expanded Applications of Magnetic Resonance Spectroscopy (MRS) Data Processing to Identify Pain and Infection Biomarkers Throughout the Body

Recent Notice of Allowance is for Aclarion’s 24th issued US patent Propionic acid (PA) is a biomarker the literature suggests…

10 months ago

Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia

No serious side effects or discomfort observed Final safety and absorption data expected in March 2025 SARASOTA, FL, Feb. 11,…

10 months ago

Firefly Neuroscience Accepted into NVIDIA Connect Program

Collaboration to provide Firefly with the technical resources to help further unleash the power of its FDA-cleared BNA™ platform          For…

10 months ago